EarningsSILVAPHL

SILVAPHL Earnings Update — FY 2022–23

Published
Last verified by BullBD

Announcement summary

What happened
SILVAPHL published a corporate disclosure on 29 October 2023. Read the full announcement for details.
Company
Silva Pharmaceuticals Limited
Announcement published

Original announcement

(Continuation news of SILVAPHL): The Company has reported EPS of Tk. 0.24, NAV per share of Tk. 17.10 and NOCFPS of Tk. 0.51 for the year ended June 30, 2023 as against Tk. 0.75, Tk. 17.03 and Tk. 1.18 respectively for the year ended June 30, 2022. Reasons for deviation in EPS and NOCFPS: EPS has decreased for lessening the sales revenue due to downtrend in local demand of product because of slowdown in the global and national economies, (cont.2)

Bangla translation

A Bangla translation is under review because critical figures or dates did not match the English disclosure.

Source & verification

Source
Published company disclosure
Published through
Dhaka Stock Exchange
Announcement ID
653dd66b9b63f84212bda2dd
Original publication
Last verified by BullBD
Translation
BullBD
Report incorrect information

Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.